CG Dimono PTx, developed by Caregen, is the first BTX type C peptide globally. Utilizing Caregen’s cutting-edge peptide technology and a specialized transdermal delivery system, it serves as an innovative alternative to conventional BTX type A treatments, offering rapid, effective, and safe outcomes. Formulated with hyaluronic acid and a sophisticated peptide complex, CG Dimono PTx is intended for injection into the mid-to-deep dermal layer where skin depressions occur. This combination instantly softens facial wrinkles and folds and functions as a skinbooster to support natural skin renewal and regeneration.